文献速递乳腺癌放疗放疗物理与技术

优化乳腺癌放疗以增强全身免疫反应:面向乳腺放疗科医生的批判性综述

Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-05-14

该综述探讨放疗尤其是高剂量新技术联合免疫检查点阻断在乳腺癌中产生全身抗肿瘤效应的潜力,指出该效应可能源于放疗局部免疫启动使效应免疫细胞扩增并循环至远处部位。综述强调需理解乳腺癌异质性与肿瘤免疫原性的关系,并掌握放疗与免疫治疗在实施、顺序和时机上的专业知识,相关临床试验正在进行。

要点

  • 高剂量新型放疗技术联合免疫治疗或可产生全身抗肿瘤效应。
  • 该效应可能由放疗局部免疫启动介导效应免疫细胞扩增并循环至远处。
  • 需解决乳腺癌异质性与免疫原性关系及放疗免疫联合的实施顺序与时机问题。

核心结论

  • 放疗尤其是高剂量新技术联合免疫检查点阻断在乳腺癌中可能产生全身抗肿瘤效应,但该概念需进一步探索并克服多项挑战。

研究设计与样本

  • 本文为面向乳腺放疗科医生的批判性综述,检索范围未在摘要中报告。

主要发现

  • 放疗的局部免疫启动效应可能导致效应免疫细胞扩增并循环至远处部位,从而产生全身抗肿瘤效应。
  • 乳腺癌异质性可能与肿瘤免疫原性相关,是需要理解的问题之一。
  • 放疗与免疫治疗在实施、顺序和时机方面需要发展知识与专长。
  • 针对上述问题的临床试验正在进行中。

临床怎么用

  • 临床实践中需关注放疗与免疫治疗联合的实施方式、顺序和时机,并考虑乳腺癌异质性与免疫原性的关系。

局限性

  • 摘要未报告综述的检索范围及具体研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunotherapy using immune checkpoint blockade has revolutionized the treatment of many types of cancer. Radiation therapy (RT)-particularly when delivered at high doses using newer techniques-may be capable of generating systemic antitumor effects when combined with immunotherapy in breast cancer. These systemic effects might be due to the local immune-priming effects of RT resulting in the expansion and circulation of effector immune cells to distant sites. Although this concept merits further exploration, several challenges need to be overcome. One is an understanding of how the heterogeneity of breast cancers may relate to tumor immunogenicity. Another concerns the need to develop knowledge and expertise in delivery, sequencing, and timing of RT with immunotherapy. Clinical trials addressing these issues are under way. We here review and discuss the particular opportunities and issues regarding this topic, including the design of informative clinical and translational studies.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ho AY, Wright JL, Blitzblau RC, et al. Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2020. PMID: 32417409. doi:10.1016/j.ijrobp.2020.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。